The pathological features of idiopathic interstitial pneumonia-associated pulmonary adenocarcinomas

Histopathology. 2017 Mar;70(4):568-578. doi: 10.1111/his.13103. Epub 2016 Dec 23.

Abstract

Aims: To investigate the pathological features of idiopathic interstitial pneumonia (IIP)-associated pulmonary adenocarcinoma.

Methods and results: Surgically resected adenocarcinomas associated with IIP (the IIP group) and adenocarcinomas without IIP (the non-IIP group) were subjected to analysis. Adenocarcinomas in the IIP group were subdivided into two groups: one group included tumours connected to bronchiolar metaplasia in honeycomb lesions (the H-IIP group), and the other included tumours unrelated to honeycomb lesions (the NH-IIP group). Histomorphological appearance and immunohistochemical expression were compared among the H-IIP group, the NH-IIP group, and the non-IIP group. Most of the tumour cells in the H-IIP group had a tall, columnar shape that showed similar features to proximal bronchial epithelium, whereas tumour cells in the NH-IIP group and the non-IIP group had a club-like shape that showed similar features to respiratory bronchiolar/alveolar epithelium. Adenocarcinomas in the H-IIP group tended to be negative for thyroid transcription factor-1 (TTF-1) and positive for hepatocyte nuclear factor-4α (HNF-4α). The frequency of EGFR mutations was significantly lower in adenocarcinomas in the H-IIP group, although the frequencies of KRAS and ALK mutations did not differ among the three groups.

Conclusions: Idiopathic interstitial pneumonia-associated pulmonary adenocarcinomas, especially those arising from honeycomb lesions, have distinct pathological features.

Keywords: histomorphological feature; idiopathic interstitial pneumonia; pulmonary adenocarcinoma.

MeSH terms

  • Adenocarcinoma / complications
  • Adenocarcinoma / pathology*
  • Aged
  • Aged, 80 and over
  • DNA Mutational Analysis
  • Disease-Free Survival
  • ErbB Receptors / genetics
  • Female
  • Humans
  • Idiopathic Interstitial Pneumonias / complications*
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Lung Neoplasms / complications
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Proto-Oncogene Proteins p21(ras) / genetics

Substances

  • KRAS protein, human
  • EGFR protein, human
  • ErbB Receptors
  • Proto-Oncogene Proteins p21(ras)